Literature DB >> 4039304

Radiosensitization of EMT6 cells by four platinum complexes.

B A Teicher, S Rockwell, J B Lee.   

Abstract

The greatest research effort in producing radiation sensitizers has been directed toward organic compounds. However, platinum complexes also have radiosensitizing capabilities, perhaps because they bind to DNA. The compound described here are dichloro complexes of bivalent platinum with one or two potentially radiosensitizing ligands. The radiosensitization of oxygenated and hypoxic exponentially growing EMT6 cells in vitro was measured. The dose modifying factors obtained with 200 microM and 400 microM trans-bis(2-nitroimidazole)dichloroplatinum II (NIPt) in hypoxic cells were 1.5 and 2.1, respectively. For trans-bis(2-amino-5-nitrothiazole)dichloroplatinum II (Plant) under the same conditions, the dose modifying factor was 1.5 at 200 microM and 1.8 at 400 microM. Neither compound sensitized oxygenated cells when tested similar protocols. Unlike the trans complexes, (1,2-diamino-4-nitrobenzene)dichloroplatinum II (Plato) was cytotoxic toward the hypoxic cells in the absence of X rays. The time course of cytotoxicity for 100 microM Plato in exponentially growing cells showed rapid killing of hypoxic cells, and much less toxicity toward oxygenated cells. In radiosensitization studies, dose modifying factors of 1.6 and 2.0 were found with 200 microM and 400 microM Plato in hypoxic cells. The compound did not sensitize aerobic cells. The well-known platinum complex cis-dipyridinedichloroplatinum II (PyPt) represents a cis-platinum heterocyclic aromatic complex that does not have a nitro-functionality. The dose modifying factor obtained with 400 microM PyPt in hypoxic cells was 1.7. On a molar basis, the nitro-functional platinum complexes appear to be more effective as hypoxic cell radiosensitizers than the corresponding free ligands.

Entities:  

Mesh:

Substances:

Year:  1985        PMID: 4039304     DOI: 10.1016/0360-3016(85)90116-6

Source DB:  PubMed          Journal:  Int J Radiat Oncol Biol Phys        ISSN: 0360-3016            Impact factor:   7.038


  10 in total

1.  Interaction of platinum complexes of thiazin and xanthene dyes with hyperthermia.

Authors:  T S Herman; B A Teicher; M R Pfeffer; V S Khandekar; E Alvarez Sotomayor
Journal:  Cancer Chemother Pharmacol       Date:  1990       Impact factor: 3.333

2.  Addition of a topoisomerase I inhibitor to trimodality therapy [cis-diamminedichloroplatinum(II)/heat/radiation] in a murine tumor.

Authors:  B A Teicher; S A Holden; V Khandakar; T S Herman
Journal:  J Cancer Res Clin Oncol       Date:  1993       Impact factor: 4.553

3.  CAI: effects on cytotoxic therapies in vitro and in vivo.

Authors:  B A Teicher; S A Holden; Y N Chen; G Ara; T T Korbut; D Northey
Journal:  Cancer Chemother Pharmacol       Date:  1994       Impact factor: 3.333

4.  beta-cyclodextrin tetradecasulfate/tetrahydrocortisol +/- minocycline as modulators of cancer therapies in vitro and in vivo against primary and metastatic Lewis lung carcinoma.

Authors:  B A Teicher; E A Sotomayor; Z D Huang; G Ara; S Holden; V Khandekar; Y N Chen
Journal:  Cancer Chemother Pharmacol       Date:  1993       Impact factor: 3.333

5.  Minocycline in combination with chemotherapy or radiation therapy in vitro and in vivo.

Authors:  E A Sotomayor; B A Teicher; G N Schwartz; S A Holden; K Menon; T S Herman; E Frei
Journal:  Cancer Chemother Pharmacol       Date:  1992       Impact factor: 3.333

6.  Report from the Radiation Therapy Committee of the Southwest Oncology Group (SWOG): Research Objectives Workshop 2008.

Authors:  Paul Okunieff; Lisa A Kachnic; Louis S Constine; Clifton D Fuller; Laurie E Gaspar; Daniel F Hayes; Jean Hooks; Clifton Ling; Frank L Meyskens; Philip A Philip; David Raben; Stephen R Smalley; Gregory P Swanson; Beverly A Teicher; Charles R Thomas; Bhadrasain Vikram; Michael J Zelefsky; Laurence H Baker
Journal:  Clin Cancer Res       Date:  2009-09-01       Impact factor: 12.531

7.  Platinum-dye complexes inhibit repair of potentially lethal damage following bleomycin treatment.

Authors:  Y Wang; T S Herman; B A Teicher
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

8.  1,2-dithiol-3-thione and dithioester analogues: potential radioprotectors.

Authors:  B A Teicher; J Stemwedel; T S Herman; P K Ghoshal; A Rosowsky
Journal:  Br J Cancer       Date:  1990-07       Impact factor: 7.640

9.  Platinum complexes inhibit repair of potentially lethal damage following bleomycin treatment.

Authors:  S A Holden; B A Teicher; K Boeheim; R R Weichselbaum; T J Ervin
Journal:  Br J Cancer       Date:  1987-03       Impact factor: 7.640

10.  Radiosensitization and hypoxic cell toxicity of NLA-1 and NLA-2, two new bioreductive compounds.

Authors:  M V Papadopoulou; M W Epperly; D S Shields; W D Bloomer
Journal:  Jpn J Cancer Res       Date:  1992-04
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.